Web: | mayocliniclabs.com |
---|---|
Email: | mcl@mayo.edu |
Telephone: | 800-533-1710 |
International: | +1 855-379-3115 |
Values are valid only on day of printing. |
Detecting drug use involving amphetamines, barbiturates, cocaine, phencyclidine, and tetrahydrocannabinol
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
AMPHU | Amphetamines Confirmation, U | Yes | No |
BARBU | Barbiturates Confirmation, U | Yes | No |
COKEU | Cocaine and metabolite Conf, U | Yes | No |
PCPU | Phencyclidine Confirmation, U | Yes | No |
THCU | Carboxy-THC Confirmation, U | Yes | No |
Testing begins with screening tests for drugs of abuse including amphetamines, barbiturates, cocaine, phencyclidine, and tetrahydrocannabinol. Positives are confirmed and quantitated by definitive methods (gas chromatography-mass spectrometry for barbiturates, cocaine and metabolites, phencyclidine, and tetrahydrocannabinol metabolite) at an additional charge. Amphetamines that screen positive will be quantified with liquid chromatography-tandem mass spectrometry at an additional charge.
Only orderable as part of profile. For more information see CSMP / Controlled Substance Monitoring Panel, Urine.
Screened by Immunoassay and Confirmed by Gas Chromatography-Mass Spectrometry (GC-MS) or Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)